Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patient With Colorectal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05582031
What this trial is testing

Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Who this might be right for
Anal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more
Translational Research in Oncology
Not applicableStudy completedNCT00499395
What this trial is testing

Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
UNC Lineberger Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT00459901
What this trial is testing

Study of the Antitumor Activity of Capecitabine in Combination With Erlotinib in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Peter Kozuch 13
Not applicableLooking for participantsNCT07830407
What this trial is testing

Pre-Clinical Validation of ChemoINTEL Unified Algorithm Chemotherapeutic Response Prediction in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Pierian Biosciences 100
Early research (Phase 1)Active Not RecruitingNCT05163028
What this trial is testing

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Who this might be right for
Non Small Cell Lung CancerColorectal CancerPancreatic Cancer+4 more
HUYABIO International, LLC. 42
Testing effectiveness (Phase 2)Looking for participantsNCT05093907
What this trial is testing

Evaluate Safety and Efficacy of BEY1107 in Combination with Capecitabine in Patients with Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
BeyondBio Inc. 27
Large-scale testing (Phase 3)UnknownNCT05948072
What this trial is testing

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 250
Not applicableUnknownNCT03572595
What this trial is testing

F-18 FDG- PETCT in Staging and Recurrent Colorectal Cancer

Who this might be right for
Colo-rectal CancerRecurrence
Assiut University 45
Not applicableUnknownNCT02751736
What this trial is testing

The Effect Of Probiotics On Bowel Function Restoration After Ileostomy Closure In Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Seoul National University Hospital 40
Not applicableStudy completedNCT02450422
What this trial is testing

The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Who this might be right for
Neoplastic Cells, Circulating
Fuda Cancer Hospital, Guangzhou 60
Testing effectiveness (Phase 2)UnknownNCT00215722
What this trial is testing

XELOX Plus Cetuximab as First-Line Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Carcinoma
Grupo de Investigacao do Cancro Digestivo 45
Testing effectiveness (Phase 2)Study completedNCT00003441
What this trial is testing

Irofulven in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 26
Post-approval studies (Phase 4)Study completedNCT06843954
What this trial is testing

Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer

Who this might be right for
Colo-rectal Cancer
Mohammed Mahmood Mohammed 157
Testing effectiveness (Phase 2)Study completedNCT00336856
What this trial is testing

Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy

Who this might be right for
Colon CancerRectum Cancer
University of Pittsburgh 35
Not applicableNot Yet RecruitingNCT07811453
What this trial is testing

Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options

Who this might be right for
Colorectal NeoplasmsLiver NeoplasmsNeoplasm Metastases+2 more
Charite University, Berlin, Germany 260
Early research (Phase 1)Active Not RecruitingNCT06540261
What this trial is testing

The Study of ONO-7913, ONO-4538 and the Standard of Care as First-line Treatment in Patients Colorectal Cancer

Who this might be right for
Unresectable Colorectal Cancer
Ono Pharmaceutical Co., Ltd. 65
Large-scale testing (Phase 3)Not Yet RecruitingNCT02448173
What this trial is testing

Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

Who this might be right for
Stage II Colon Cancer
Vaccinogen Inc 550
Testing effectiveness (Phase 2)UnknownNCT03076957
What this trial is testing

A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.

Who this might be right for
Colorectal Cancer
Chong Kun Dang Pharmaceutical 24
Testing effectiveness (Phase 2)Looking for participantsNCT07030257
What this trial is testing

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor MalignanciesColorectal CarcinomaSmall Cell Lung Cancer ( SCLC )+4 more
Tasca Therapeutics 150
Testing effectiveness (Phase 2)Ended earlyNCT00126451
What this trial is testing

A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)

Who this might be right for
Breast CancerColorectal CancerNon-small-cell Lung Carcinoma
Merck Sharp & Dohme LLC 16
Next Page